Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Farrell

Showing results (271-280 of 522) with videos related to

Pageof 53
Sort By:
The Lancet. Psychiatry|January 17, 2018
The effect of a potentially tamper-resistant oxycodone formulation on opioid use and harm: main findings of the National Opioid Medications Abuse Deterrence (NOMAD) studyBriony Larance, Timothy Dobbins, Amy Peacock, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 2, 2005
Alcohol consumption as a risk factor for anxiety and depression: results from the longitudinal follow-up of the National Psychiatric Morbidity SurveyJonathan C Haynes, Michael Farrell, Nicola Singleton, et al.
The Lancet. Public Health|June 16, 2019
The effect of entry and retention in opioid agonist treatment on contact with the criminal justice system among opioid-dependent people: a retrospective cohort studyNatasa Gisev, Chrianna Bharat, Sarah Larney, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|June 7, 2003
Drug-related mortality and fatal overdose risk: pilot cohort study of heroin users recruited from specialist drug treatment sites in LondonMatthew Hickman, Zenobia Carnwath, Peter Madden, et al.
Journal of Parkinson'S Disease|December 16, 2020
On the Emergence of Tremor in Prodromal Parkinson's DiseaseConor Fearon, Andrew J Lees, John J McKinley, et al.
The International Journal on Drug Policy|July 11, 2022
Can a new formulation of opiate agonist treatment alter stigma?: Place, time and things in the experience of extended-release buprenorphine depotCarla Treloar, Kari Lancaster, Sandra Gendera, et al.
Drug and Alcohol Review|April 18, 2024
Enhancing the SUSTAINable uptake of evidence to minimise harms from alcohol and other drugs in New South Wales, AustraliaSara Farnbach, Catherine Foley, Peter Gates, et al.
Journal of Pediatric Gastroenterology and Nutrition|September 15, 2017
Development of the Aim to Decrease Anxiety and Pain Treatment for Pediatric Functional Abdominal Pain DisordersNatoshia R Cunningham, Sarah Nelson, Anjana Jagpal, et al.
Current Neurology and Neuroscience Reports|February 15, 2018
The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of ReviewsSuzanne Nielsen, Rada Germanos, Megan Weier, et al.
Veterinary Surgery : VS|July 21, 2011
In vitro performance testing of two arcuate oscillating saw blades designed for use during tibial plateau leveling osteotomyMichael Farrell, Andrew Mathieson, Peter Chung, et al.
Pageof 53

Showing results (271-280 of 522) with videos related to

Sort By:
Pageof 53
The Lancet. Psychiatry|January 17, 2018
The effect of a potentially tamper-resistant oxycodone formulation on opioid use and harm: main findings of the National Opioid Medications Abuse Deterrence (NOMAD) studyBriony Larance, Timothy Dobbins, Amy Peacock, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 2, 2005
Alcohol consumption as a risk factor for anxiety and depression: results from the longitudinal follow-up of the National Psychiatric Morbidity SurveyJonathan C Haynes, Michael Farrell, Nicola Singleton, et al.
The Lancet. Public Health|June 16, 2019
The effect of entry and retention in opioid agonist treatment on contact with the criminal justice system among opioid-dependent people: a retrospective cohort studyNatasa Gisev, Chrianna Bharat, Sarah Larney, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|June 7, 2003
Drug-related mortality and fatal overdose risk: pilot cohort study of heroin users recruited from specialist drug treatment sites in LondonMatthew Hickman, Zenobia Carnwath, Peter Madden, et al.
Journal of Parkinson'S Disease|December 16, 2020
On the Emergence of Tremor in Prodromal Parkinson's DiseaseConor Fearon, Andrew J Lees, John J McKinley, et al.
The International Journal on Drug Policy|July 11, 2022
Can a new formulation of opiate agonist treatment alter stigma?: Place, time and things in the experience of extended-release buprenorphine depotCarla Treloar, Kari Lancaster, Sandra Gendera, et al.
Drug and Alcohol Review|April 18, 2024
Enhancing the SUSTAINable uptake of evidence to minimise harms from alcohol and other drugs in New South Wales, AustraliaSara Farnbach, Catherine Foley, Peter Gates, et al.
Journal of Pediatric Gastroenterology and Nutrition|September 15, 2017
Development of the Aim to Decrease Anxiety and Pain Treatment for Pediatric Functional Abdominal Pain DisordersNatoshia R Cunningham, Sarah Nelson, Anjana Jagpal, et al.
Current Neurology and Neuroscience Reports|February 15, 2018
The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of ReviewsSuzanne Nielsen, Rada Germanos, Megan Weier, et al.
Veterinary Surgery : VS|July 21, 2011
In vitro performance testing of two arcuate oscillating saw blades designed for use during tibial plateau leveling osteotomyMichael Farrell, Andrew Mathieson, Peter Chung, et al.
Pageof 53